cfDNA / cfRNA NGS ºÐ¼®À» À§ÇÑ Ãßõ Á¦Ç°
Cell-free Nucleic Acid Sequencing
Cell-free nucleic acid·ÎºÎÅÍ ´õ ªÀº ½Ã°£À¸·Î, ´õ ÁÁÀº °á°ú¸¦
¾×ü »ý°Ë (Liquid-biopsy) ºÐ¼®¹ý °³¹ßÀÇ ½ºÇǵå¾÷!
¡°ThruPLEX¢ç Plasma-Seq Kit´Â µû¶óÇÏ±â ¸Å¿ì ½±°í, °£¼ÒÈµÈ ÇÁ·ÎÅäÄÝÀ» °¡Áö°í ÀÖ½À´Ï´Ù. °¡Àå Áß¿äÇÑ °ÍÀº clean-up ´Ü°è°¡ ¸Å¿ì Àû´Ù´Â °ÍÀÔ´Ï´Ù. ¿ì¸®´Â 1 ngÀÇ ½Ã·á·Î ¼º°øÀûÀ¸·Î NGS library¸¦ Á¦ÀÛÇÏ¿´½À´Ï´Ù.¡±
Dr. Charlie Massie, UNIVERSITY OF CAMBRIDGE
[Cell-free DNA (cfDNA)]
ThruPLEX¢ç Plasma-Seq Kit for cell-free DNA (cfDNA)
È¿À²ÀûÀÌ°í °£°áÇÑ ÇÁ·ÎÅäÄÝ (streamlined protocol)Àº ´õ ÀûÀº ¾çÀÇ »ùÇ÷Π¸Å¿ì ªÀº hands-on-timeÀ» ÅëÇØ ´õ ºü¸¥ °á°ú¸¦ ¾òÀ» ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, »ùÇà °£, NGS run ¹×
½ÇÇèÀÚ °£ÀÇ ¿ÀÂ÷¸¦ ÁÙÀÏ ¼ö ÀÖ¾î, º¸´Ù ÀçÇö¼º°ú ½Å·Ú¼ºÀÌ ³ôÀº °á°ú¸¦ Á¦°øÇÒ ¼ö ÀÖ´Ù.
ThruPLEX¢ç Plasma-Seq Kit´Â
cell-free DNA ºÐ¼®À» À§ÇØ °³¹ßµÇ¾úÀ¸¸ç, ÃÖÀûÈ µÇ¾îÀÖ´Ù.
ÀÌ Çõ½ÅÀûÀÎ Á¦Ç°ÀÇ ÀåÁ¡Àº ¾Æ·¡¿Í °°´Ù.
- Single-tube workflow: Tube transfer¿Í Á¤Á¦ °úÁ¤ ºÒÇÊ¿ä
- Ultra-fast protocol: 3´Ü°è ÇÁ·ÎÅäÄÝ·Î 2½Ã°£¿¡ Á¦ÀÛ ¿Ï·á
- Optimized reagents: ÀûÀýÇÑ adapter ³óµµ·Î ÃÖÀûÈ µÇ¾îÀÖ¾î Á¤·® ºÒÇÊ¿ä
- Superior performance: high-complexity NGS library Á¦ÀÛÀº ¹°·Ð, ÀçÇö¼º ÀÖ´Â °á°ú µµÃâ °¡´É
±×¸² 1. ½ÇÇè ´Ü°è¿Í Pipetting Ƚ¼ö °¨¼Ò·Î, ½ÇÇèÀÇ ÀçÇö¼º°ú ¹Î°¨µµ Áõ°¡
ThruPLEX¢ç Plasma-Seq Kit·Î library¸¦ Á¦ÀÛÇÑ °á°ú, 9°³ÀÇ Ç÷Àå »ùÇà (Plasma sample)°£ÀÇ ÇöÀúÇÏ°Ô ÀûÀº ¿ÀÂ÷·Î ³ôÀº ÀçÇö¼ºÀ» º¸¿´À» »Ó ¾Æ´Ï¶ó, Human GenomeÀÇ
GC coverage¿¡ ´ëÇØ ÆíÇ⼺ÀÌ ¾ø´Â µ¥ÀÌÅ͸¦ ¾òÀ» ¼ö ÀÖ¾ú´Ù. Library´Â 1 §¢ÀÇ Ç÷Àå »ùÇ÷κÎÅÍ ¾ò¾îÁø cell-free DNA·ÎºÎÅÍ Á¦ÀÛÇÏ¿´°í, Illumina¢ç NextSeq¢ç 500¸¦ ÀÌ¿ëÇØ ºÐ¼®ÇÏ¿´´Ù.
NEBNext¢ç Ultra libraries´Â °¢°¢ ´Ù¸¥ ³× °³ÀÇ Ç÷Àå »ùÇÃÀ» »ç¿ëÇÏ¿´´Ù.
ThruPLEX
¢ç ±â¼úÀÇ ¶Ù¾î³ ¼º´ÉÀº cell-free DNA »ùÇÃÀ» ÀÌ¿ëÇÑ ½ÇÇèÀÇ ÇѰ踦 ±Øº¹ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, ¾×ü »ý°Ë ºÐ¼®ÀÇ ¿µ¿ªÀ» ¹ßÀü½ÃÅ´À¸·Î½á ÀÓ»ó È¿¿ë¼ºÀ» °ËÁõÇÒ ¼ö ÀÖ´Ù.
¨ç
Kitzman et al.Àº ºñħ½ÀÀûÀÎ ¹æ¹ýÀ¸·Î žÆÀÇ À¯Àüü ¼¿À» ºÐ¼®Çϱâ À§ÇÏ¿©, ThruPLEX
¢ç Plasma-Seq Kit¸¦ ÀÌ¿ëÇØ ¸ðüÀÇ Ç÷Àå¿¡¼ ÃßÃâÇÑ
cell-free DNAÀÇ NGS Library¸¦ Á¦ÀÛÇÏ¿´´Ù.
¨è
Murtaza et al.Àº ºñħ½ÀÀû ¹æ¹ýÀ¸·Î ¾ò¾îÁø ȯÀÚÀÇ cell-free DNA¸¦ ÀÌ¿ëÇØ Ä¡·á ÀüÈÄÀÇ È¯ÀÚÀÇ Á¾¾ç º¯È¸¦ ¸ð´ÏÅ͸µ ÇÏ°íÀÚ, ThruPLEX
¢ç
Plasma-Seq Kit¸¦ ÀÌ¿ëÇÏ¿© ctDNA¿¡ ´ëÇÑ Whole Exome NGSºÐ¼®À» ½Ç½ÃÇÏ¿´´Ù.
¨é ÃÖ±Ù,
À§½ºÄܽŠÀÇ°ú´ëÇаú Mayo ClinicÀÇ ¿¬±¸ÀÚµéÀº Àü¸³¼±¾Ï, Æó¾Ï, ´ëÀå¾ÏÀÇ cell-free DNA ¹ÙÀÌ¿À¸¶Ä¿¸¦ ±Ô¸íÇϱâ À§ÇØ ThruPLEX
¢ç Plasma-Seq Kit¸¦
Àû¿ëÇÏ°í ÀÖ´Ù (¾Æ·¡ÀÇ Webinar¸¦ ÂüÁ¶Çϼ¼¿ä).
[Cell-free RNA (cfRNA)]
Stranded Total RNA-Seq Kit v2-Pico Input Mammalian for cell-free RNA (cfRNA)
Cell-free RNA ºÐ¼®À» À§Çؼ´Â ¹Î°¨µµ ³ôÀº Illumina
¢ç¿ë stranded NGS library Á¦ÀÛÀÌ ÇÊ¿äÇϸç, À̸¦ À§ÇØ, ´ÙÄ«¶ó¹ÙÀÌ¿À´Â
Stranded Total RNA-Seq Kit v2-Pico Input Mammalian (ÀÌÇÏ, Pico v2)¸¦ Á¦°øÇÑ´Ù. ÀÌ Á¦Ç°Àº Ç÷ÀåÀ̳ª ´Ù¸¥ »ýü¾× (biofluid)·ÎºÎÅÍ À¯·¡µÈ cell-free RNA
(250 pg -10 ng total RNA)¸¦ ÀÌ¿ëÇØ °íÇ°ÁúÀÇ stranded NGS library¸¦ 6½Ã°£ ¸¸¿¡ Á¦ÀÛÇÒ ¼ö ÀÖ´Ù. ¾Æ·¡ÀÇ µ¥ÀÌÅÍ´Â ÀϹÝÀûÀ¸·Î ±ÇÀåÇÏ´Â 1 ng RNAÀÇ ¾çÀ» »ç¿ëÇÏ¿´À»
¶§¿Í 150 pgÀÇ ¾ÆÁÖ ÀûÀº ¾çÀÇ RNAÀ» »ç¿ëÇÏ¿´À» ¶§ÀÇ µ¥ÀÌÅÍ·Î, º» Á¦Ç°ÀÌ ¾ó¸¶³ª ³ôÀº ¹Î°¨µµ¸¦ °¡Áö´Â Áö¸¦ È®ÀÎÇÒ ¼ö ÀÖ´Ù.
´õ ¸¹Àº Á¤º¸¸¦ º¸½Ã·Á¸é,
Technical Note¸¦ ÂüÁ¶Çϼ¼¿ä.
±×¸² 2. Pico v2¸¦ ÀÌ¿ëÇÑ pico gram ¼öÁØÀÇ cell-free RNA °í°¨µµ ºÐ¼®
Stranded Total RNA-Seq Kit v2-Pico Input MammalianÀÇ ÃßõÇÏ´Â RNA input ¾çÀº 1 ngÀÌÁö¸¸, ´õ ÀûÀº ¾çÀÇ cell-free RNA·Î °íÇ°ÁúÀÇ NGS library¸¦ °¨µµ ÀÖ°Ô
Á¦ÀÛ °¡´ÉÇÏ´Ù. º» µ¥ÀÌÅÍ´Â 150 pg°ú 1 ngÀ» ÀÌ¿ëÇßÀ» ¶§, Pico v1°ú Pico v2ÀÇ ¼º´ÉÀ» ºñ±³ÇÏ¿´´Ù. Pico v2´Â ³·Àº ribosomal reads, mitochondrial reads ¸¦ ³ªÅ¸³»¾úÀ¸¸ç
³ôÀº À¯ÀüÀÚ °ËÃâ ¼ö¿Í º¸´Ù Çâ»óµÈ ¼º´ÉÀ» º¸¿´´Ù.
References
Kitzman, J.O.
et al. Noninvasive Whole-Genome Sequencing of a Human Fetus.
Sci. Transl. Med. 4, 137-176 (2012).
Murtaza, M.
et al. Non-invasive analysis of acquired resistance to cancer therapy by Sequencing of plasma DNA.
Nature 497, 108-112 (2013).
[Á¦Ç°Á¤º¸]